Claudio Brunstein, MD
Cleveland Clinic Foundation, Case Comprehensive Cancer Center · Masonic Cancer Center, University of Minnesota · University of Minnesota
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Claudio Brunstein, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:40 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06129734 · Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell TransplantBenjamin Tomlinson · recruiting · Myeloid Malignancy, Acute Myeloid Leukemia · principal investigator
- Ph2NCT02991898 · Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme MalignanciesMasonic Cancer Center, University of Minnesota · terminated · Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies · principal investigator
- Ph2NCT02989844 · Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCTMasonic Cancer Center, University of Minnesota · completed · Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) · principal investigator
- N/ANCT02145039 · Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic DiseasesMasonic Cancer Center, University of Minnesota · terminated · Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia · principal investigator
- Ph2NCT02118311 · Treg Cells for AGVHD in Non-myeloablative UCB TransplantMasonic Cancer Center, University of Minnesota · withdrawn · Hematologic Malignancies · principal investigator
- N/ANCT01962636 · Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological DiseasesMasonic Cancer Center, University of Minnesota · terminated · Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia · principal investigator
- Ph1/Ph2NCT01163201 · T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesMasonic Cancer Center, University of Minnesota · withdrawn · Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia · principal investigator
- Ph2/Ph3NCT00177047 · Autologous Transplant for Multiple MyelomaMasonic Cancer Center, University of Minnesota · completed · Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Off-the-shelf iPSC-Derived Natural Killer Cell Immunotherapies for AMLP01CA065493 · NCI · UNIVERSITY OF MINNESOTA · PI Jeffrey S. Miller · fiscal years 1995 to 2026Named on NCT02118311
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.